Trials / Completed
CompletedNCT04608682
Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording
Effect of Intraoperative Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 170 (actual)
- Sponsor
- Beijing Tiantan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Transcranial motor evoked potential (TcMEP) monitoring is conventionally performed during surgery without or with minimal neuromuscular blockade (NMB) because of its potential interference with signal interpretation.The feasibility of TcMEP interpretation was assessed during partial NMB in adult neurosurgical patients. However, partial NMB may interfere record of TcMEP monitoring. Sugammadex is the first highly selective antagonist that can reverse NMB. This study aims to evaluate the success rate of intraoperative muscle relax reversal by sugammadex on intraoperative TceMEP recording.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sugammadex | The muscle relaxant infusion will be discontinued and a bolus of sugammadex (2mg/kg) will be given while performing TceMEPs. |
| DRUG | Saline | The muscle relaxant infusion will be discontinued and 2ml saline will be infused, TceMEPs monitoring will be performed 5 minutes later. |
Timeline
- Start date
- 2021-08-16
- Primary completion
- 2022-08-30
- Completion
- 2022-08-30
- First posted
- 2020-10-29
- Last updated
- 2022-09-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04608682. Inclusion in this directory is not an endorsement.